HEADER MEMBRANE PROTEIN 08-JAN-18 6FFI TITLE CRYSTAL STRUCTURE OF MGLUR5 IN COMPLEX WITH MMPEP AT 2.2 A COMPND MOL_ID: 1; COMPND 2 MOLECULE: METABOTROPIC GLUTAMATE RECEPTOR 5,ENDOLYSIN,METABOTROPIC COMPND 3 GLUTAMATE RECEPTOR 5; COMPND 4 CHAIN: A; COMPND 5 FRAGMENT: MGLUR5,MGLUR5,MGLUR5,MGLUR5,MGLUR5,MGLUR5,MGLUR5,MGLUR5, COMPND 6 MGLUR5; COMPND 7 SYNONYM: MGLUR5,LYSIS PROTEIN,LYSOZYME,MURAMIDASE,MGLUR5; COMPND 8 EC: 3.2.1.17; COMPND 9 ENGINEERED: YES; COMPND 10 MUTATION: YES; COMPND 11 OTHER_DETAILS: CHIMERIC CONSTRUCT OF HUMAN MGLU5 (GRM5) WITH A COMPND 12 BACTERIOPHAGE T4 LYSOZYME (P00720) INSERTION IN INTRACELLULAR LOOP 2 COMPND 13 BETWEEN RESIDUES LYS678 AND LYS679.,CHIMERIC CONSTRUCT OF HUMAN MGLU5 COMPND 14 (GRM5) WITH A BACTERIOPHAGE T4 LYSOZYME (P00720) INSERTION IN COMPND 15 INTRACELLULAR LOOP 2 BETWEEN RESIDUES LYS678 AND LYS679.,CHIMERIC COMPND 16 CONSTRUCT OF HUMAN MGLU5 (GRM5) WITH A BACTERIOPHAGE T4 LYSOZYME COMPND 17 (P00720) INSERTION IN INTRACELLULAR LOOP 2 BETWEEN RESIDUES LYS678 COMPND 18 AND LYS679.,CHIMERIC CONSTRUCT OF HUMAN MGLU5 (GRM5) WITH A COMPND 19 BACTERIOPHAGE T4 LYSOZYME (P00720) INSERTION IN INTRACELLULAR LOOP 2 COMPND 20 BETWEEN RESIDUES LYS678 AND LYS679.,CHIMERIC CONSTRUCT OF HUMAN MGLU5 COMPND 21 (GRM5) WITH A BACTERIOPHAGE T4 LYSOZYME (P00720) INSERTION IN COMPND 22 INTRACELLULAR LOOP 2 BETWEEN RESIDUES LYS678 AND LYS679.,CHIMERIC COMPND 23 CONSTRUCT OF HUMAN MGLU5 (GRM5) WITH A BACTERIOPHAGE T4 LYSOZYME COMPND 24 (P00720) INSERTION IN INTRACELLULAR LOOP 2 BETWEEN RESIDUES LYS678 COMPND 25 AND LYS679.,CHIMERIC CONSTRUCT OF HUMAN MGLU5 (GRM5) WITH A COMPND 26 BACTERIOPHAGE T4 LYSOZYME (P00720) INSERTION IN INTRACELLULAR LOOP 2 COMPND 27 BETWEEN RESIDUES LYS678 AND LYS679.,CHIMERIC CONSTRUCT OF HUMAN MGLU5 COMPND 28 (GRM5) WITH A BACTERIOPHAGE T4 LYSOZYME (P00720) INSERTION IN COMPND 29 INTRACELLULAR LOOP 2 BETWEEN RESIDUES LYS678 AND LYS679.,CHIMERIC COMPND 30 CONSTRUCT OF HUMAN MGLU5 (GRM5) WITH A BACTERIOPHAGE T4 LYSOZYME COMPND 31 (P00720) INSERTION IN INTRACELLULAR LOOP 2 BETWEEN RESIDUES LYS678 COMPND 32 AND LYS679. SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS, ENTEROBACTERIA PHAGE T4; SOURCE 3 ORGANISM_COMMON: HUMAN, BACTERIOPHAGE T4; SOURCE 4 ORGANISM_TAXID: 9606, 10665; SOURCE 5 GENE: GRM5, GPRC1E, MGLUR5; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: SF21; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: BACMID KEYWDS 7TM, RECEPTOR, GPCR, MEMBRANE-PROTEIN, SIGNALING PROTEIN, MEMBRANE KEYWDS 2 PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR J.A.CHRISTOPHER,Z.ORGOVAN,M.CONGREVE,A.S.DORE,J.C.ERREY,F.H.MARSHALL, AUTHOR 2 J.S.MASON,K.OKRASA,P.RUCKTOOA,M.J.SERRANO-VEGA,G.G.FERENCZY, AUTHOR 3 G.M.KESERU REVDAT 5 17-JAN-24 6FFI 1 REMARK REVDAT 4 24-APR-19 6FFI 1 SOURCE JRNL REVDAT 3 28-MAR-18 6FFI 1 JRNL REVDAT 2 14-MAR-18 6FFI 1 JRNL REVDAT 1 07-MAR-18 6FFI 0 JRNL AUTH J.A.CHRISTOPHER,Z.ORGOVAN,M.CONGREVE,A.S.DORE,J.C.ERREY, JRNL AUTH 2 F.H.MARSHALL,J.S.MASON,K.OKRASA,P.RUCKTOOA,M.J.SERRANO-VEGA, JRNL AUTH 3 G.G.FERENCZY,G.M.KESERU JRNL TITL STRUCTURE-BASED OPTIMIZATION STRATEGIES FOR G JRNL TITL 2 PROTEIN-COUPLED RECEPTOR (GPCR) ALLOSTERIC MODULATORS: A JRNL TITL 3 CASE STUDY FROM ANALYSES OF NEW METABOTROPIC GLUTAMATE JRNL TITL 4 RECEPTOR 5 (MGLU5) X-RAY STRUCTURES. JRNL REF J.MED.CHEM. V. 62 207 2019 JRNL REFN ISSN 0022-2623 JRNL PMID 29455526 JRNL DOI 10.1021/ACS.JMEDCHEM.7B01722 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.8.1_1168 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.99 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 93.7 REMARK 3 NUMBER OF REFLECTIONS : 23969 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.228 REMARK 3 R VALUE (WORKING SET) : 0.226 REMARK 3 FREE R VALUE : 0.269 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.860 REMARK 3 FREE R VALUE TEST SET COUNT : 1164 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 19.9917 - 4.3865 0.89 2782 146 0.1988 0.2238 REMARK 3 2 4.3865 - 3.4877 0.92 2845 144 0.1860 0.2017 REMARK 3 3 3.4877 - 3.0486 0.94 2849 149 0.2168 0.2873 REMARK 3 4 3.0486 - 2.7706 0.93 2819 130 0.2345 0.2802 REMARK 3 5 2.7706 - 2.5725 0.95 2865 123 0.2633 0.4021 REMARK 3 6 2.5725 - 2.4211 0.97 2917 160 0.2888 0.3326 REMARK 3 7 2.4211 - 2.3000 0.95 2866 158 0.2979 0.3477 REMARK 3 8 2.3000 - 2.2000 0.96 2862 154 0.3273 0.4087 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.360 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 31.350 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 33.16 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.89 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.004 3411 REMARK 3 ANGLE : 0.827 4592 REMARK 3 CHIRALITY : 0.055 527 REMARK 3 PLANARITY : 0.004 557 REMARK 3 DIHEDRAL : 14.398 1290 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6FFI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 08-JAN-18. REMARK 100 THE DEPOSITION ID IS D_1200008047. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-APR-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I24 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.96862 REMARK 200 MONOCHROMATOR : SI REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.2.17 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24147 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 30.810 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.4 REMARK 200 DATA REDUNDANCY : 2.500 REMARK 200 R MERGE (I) : 0.14200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.27 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.5 REMARK 200 DATA REDUNDANCY IN SHELL : 2.60 REMARK 200 R MERGE FOR SHELL (I) : 1.03800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4OO9 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.16 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.52 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 24-34% V/V PEG400, 0.2 M AMMONIUM REMARK 280 PHOSPHATE DIBASIC, 0.1 M MES, PH 6.8, LIPIDIC CUBIC PHASE, REMARK 280 TEMPERATURE 293.1K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 71.41100 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 21.71200 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 71.41100 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 21.71200 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3430 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20990 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 25.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 566 REMARK 465 ALA A 567 REMARK 465 CYS A 841 REMARK 465 THR A 842 REMARK 465 LYS A 843 REMARK 465 LYS A 844 REMARK 465 PRO A 845 REMARK 465 ARG A 846 REMARK 465 PHE A 847 REMARK 465 MET A 848 REMARK 465 HIS A 881 REMARK 465 ASP A 882 REMARK 465 TYR A 883 REMARK 465 PRO A 884 REMARK 465 SER A 885 REMARK 465 ILE A 886 REMARK 465 ARG A 887 REMARK 465 VAL A 993 REMARK 465 ARG A 994 REMARK 465 SER A 995 REMARK 465 ALA A 996 REMARK 465 ALA A 997 REMARK 465 ALA A 998 REMARK 465 ALA A 999 REMARK 465 HIS A 1000 REMARK 465 HIS A 1001 REMARK 465 HIS A 1002 REMARK 465 HIS A 1003 REMARK 465 HIS A 1004 REMARK 465 HIS A 1005 REMARK 465 HIS A 1006 REMARK 465 HIS A 1007 REMARK 465 HIS A 1008 REMARK 465 HIS A 1009 REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 OLA A 4002 REMARK 610 OLA A 4003 REMARK 610 OLA A 4004 REMARK 610 OLA A 4005 REMARK 610 OLA A 4007 REMARK 610 OLA A 4008 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLA A 4001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLA A 4002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLA A 4003 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLA A 4004 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLA A 4005 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MES A 4006 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLA A 4007 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLA A 4008 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue D8B A 4009 DBREF 6FFI A 569 678 UNP P41594 GRM5_HUMAN 569 678 DBREF 6FFI A 679 839 UNP P00720 ENLYS_BPT4 2 162 DBREF 6FFI A 840 996 UNP P41594 GRM5_HUMAN 680 836 SEQADV 6FFI ALA A 566 UNP P41594 EXPRESSION TAG SEQADV 6FFI ALA A 567 UNP P41594 EXPRESSION TAG SEQADV 6FFI SER A 568 UNP P41594 EXPRESSION TAG SEQADV 6FFI ALA A 579 UNP P41594 GLU 579 ENGINEERED MUTATION SEQADV 6FFI TYR A 667 UNP P41594 ASN 667 ENGINEERED MUTATION SEQADV 6FFI ALA A 669 UNP P41594 ILE 669 ENGINEERED MUTATION SEQADV 6FFI MET A 675 UNP P41594 GLY 675 ENGINEERED MUTATION SEQADV 6FFI GLY A 689 UNP P00720 ARG 12 CONFLICT SEQADV 6FFI THR A 731 UNP P00720 CYS 54 CONFLICT SEQADV 6FFI ALA A 774 UNP P00720 CYS 97 CONFLICT SEQADV 6FFI ARG A 814 UNP P00720 ILE 137 CONFLICT SEQADV 6FFI ALA A 902 UNP P41594 THR 742 ENGINEERED MUTATION SEQADV 6FFI ALA A 913 UNP P41594 SER 753 ENGINEERED MUTATION SEQADV 6FFI ALA A 997 UNP P41594 EXPRESSION TAG SEQADV 6FFI ALA A 998 UNP P41594 EXPRESSION TAG SEQADV 6FFI ALA A 999 UNP P41594 EXPRESSION TAG SEQADV 6FFI HIS A 1000 UNP P41594 EXPRESSION TAG SEQADV 6FFI HIS A 1001 UNP P41594 EXPRESSION TAG SEQADV 6FFI HIS A 1002 UNP P41594 EXPRESSION TAG SEQADV 6FFI HIS A 1003 UNP P41594 EXPRESSION TAG SEQADV 6FFI HIS A 1004 UNP P41594 EXPRESSION TAG SEQADV 6FFI HIS A 1005 UNP P41594 EXPRESSION TAG SEQADV 6FFI HIS A 1006 UNP P41594 EXPRESSION TAG SEQADV 6FFI HIS A 1007 UNP P41594 EXPRESSION TAG SEQADV 6FFI HIS A 1008 UNP P41594 EXPRESSION TAG SEQADV 6FFI HIS A 1009 UNP P41594 EXPRESSION TAG SEQRES 1 A 444 ALA ALA SER PRO VAL GLN TYR LEU ARG TRP GLY ASP PRO SEQRES 2 A 444 ALA PRO ILE ALA ALA VAL VAL PHE ALA CYS LEU GLY LEU SEQRES 3 A 444 LEU ALA THR LEU PHE VAL THR VAL VAL PHE ILE ILE TYR SEQRES 4 A 444 ARG ASP THR PRO VAL VAL LYS SER SER SER ARG GLU LEU SEQRES 5 A 444 CYS TYR ILE ILE LEU ALA GLY ILE CYS LEU GLY TYR LEU SEQRES 6 A 444 CYS THR PHE YCM LEU ILE ALA LYS PRO LYS GLN ILE TYR SEQRES 7 A 444 CYS TYR LEU GLN ARG ILE GLY ILE GLY LEU SER PRO ALA SEQRES 8 A 444 MET SER TYR SER ALA LEU VAL THR LYS THR TYR ARG ALA SEQRES 9 A 444 ALA ARG ILE LEU ALA MET SER LYS LYS ASN ILE PHE GLU SEQRES 10 A 444 MET LEU ARG ILE ASP GLU GLY LEU ARG LEU LYS ILE TYR SEQRES 11 A 444 LYS ASP THR GLU GLY TYR TYR THR ILE GLY ILE GLY HIS SEQRES 12 A 444 LEU LEU THR LYS SER PRO SER LEU ASN ALA ALA LYS SER SEQRES 13 A 444 GLU LEU ASP LYS ALA ILE GLY ARG ASN THR ASN GLY VAL SEQRES 14 A 444 ILE THR LYS ASP GLU ALA GLU LYS LEU PHE ASN GLN ASP SEQRES 15 A 444 VAL ASP ALA ALA VAL ARG GLY ILE LEU ARG ASN ALA LYS SEQRES 16 A 444 LEU LYS PRO VAL TYR ASP SER LEU ASP ALA VAL ARG ARG SEQRES 17 A 444 ALA ALA LEU ILE ASN MET VAL PHE GLN MET GLY GLU THR SEQRES 18 A 444 GLY VAL ALA GLY PHE THR ASN SER LEU ARG MET LEU GLN SEQRES 19 A 444 GLN LYS ARG TRP ASP GLU ALA ALA VAL ASN LEU ALA LYS SEQRES 20 A 444 SER ARG TRP TYR ASN GLN THR PRO ASN ARG ALA LYS ARG SEQRES 21 A 444 VAL ILE THR THR PHE ARG THR GLY THR TRP ASP ALA TYR SEQRES 22 A 444 LYS ILE CYS THR LYS LYS PRO ARG PHE MET SER ALA CYS SEQRES 23 A 444 ALA GLN LEU VAL ILE ALA PHE ILE LEU ILE CYS ILE GLN SEQRES 24 A 444 LEU GLY ILE ILE VAL ALA LEU PHE ILE MET GLU PRO PRO SEQRES 25 A 444 ASP ILE MET HIS ASP TYR PRO SER ILE ARG GLU VAL TYR SEQRES 26 A 444 LEU ILE CYS ASN THR THR ASN LEU GLY VAL VAL ALA PRO SEQRES 27 A 444 LEU GLY TYR ASN GLY LEU LEU ILE LEU ALA CYS THR PHE SEQRES 28 A 444 TYR ALA PHE LYS THR ARG ASN VAL PRO ALA ASN PHE ASN SEQRES 29 A 444 GLU ALA LYS TYR ILE ALA PHE THR MET TYR THR THR CYS SEQRES 30 A 444 ILE ILE TRP LEU ALA PHE VAL PRO ILE TYR PHE GLY SER SEQRES 31 A 444 ASN TYR LYS ILE ILE THR MET CYS PHE SER VAL SER LEU SEQRES 32 A 444 SER ALA THR VAL ALA LEU GLY CYS MET PHE VAL PRO LYS SEQRES 33 A 444 VAL TYR ILE ILE LEU ALA LYS PRO GLU ARG ASN VAL ARG SEQRES 34 A 444 SER ALA ALA ALA ALA HIS HIS HIS HIS HIS HIS HIS HIS SEQRES 35 A 444 HIS HIS MODRES 6FFI YCM A 634 CYS MODIFIED RESIDUE HET YCM A 634 10 HET OLA A4001 20 HET OLA A4002 15 HET OLA A4003 14 HET OLA A4004 13 HET OLA A4005 11 HET MES A4006 12 HET OLA A4007 11 HET OLA A4008 14 HET D8B A4009 17 HETNAM YCM S-(2-AMINO-2-OXOETHYL)-L-CYSTEINE HETNAM OLA OLEIC ACID HETNAM MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID HETNAM D8B 2-[2-(3-METHOXYPHENYL)ETHYNYL]-6-METHYL-PYRIDINE HETSYN YCM CYSTEINE-S-ACETAMIDE FORMUL 1 YCM C5 H10 N2 O3 S FORMUL 2 OLA 7(C18 H34 O2) FORMUL 7 MES C6 H13 N O4 S FORMUL 10 D8B C15 H13 N O FORMUL 11 HOH *142(H2 O) HELIX 1 AA1 SER A 568 TRP A 575 1 8 HELIX 2 AA2 PRO A 578 TYR A 604 1 27 HELIX 3 AA3 THR A 607 SER A 612 1 6 HELIX 4 AA4 SER A 614 CYS A 631 1 18 HELIX 5 AA5 CYS A 631 ILE A 636 1 6 HELIX 6 AA6 LYS A 640 GLU A 688 1 49 HELIX 7 AA7 SER A 715 GLY A 728 1 14 HELIX 8 AA8 THR A 736 ARG A 757 1 22 HELIX 9 AA9 LEU A 761 LEU A 768 1 8 HELIX 10 AB1 ASP A 769 ALA A 789 1 21 HELIX 11 AB2 PHE A 791 GLN A 800 1 10 HELIX 12 AB3 ARG A 802 ALA A 811 1 10 HELIX 13 AB4 SER A 813 THR A 819 1 7 HELIX 14 AB5 THR A 819 GLY A 833 1 15 HELIX 15 AB6 ALA A 850 GLU A 875 1 26 HELIX 16 AB7 THR A 896 THR A 921 1 26 HELIX 17 AB8 PRO A 925 GLY A 954 1 30 HELIX 18 AB9 TYR A 957 LYS A 988 1 32 SHEET 1 AA1 3 ARG A 691 LYS A 696 0 SHEET 2 AA1 3 TYR A 702 GLY A 705 -1 O THR A 703 N TYR A 695 SHEET 3 AA1 3 HIS A 708 LEU A 709 -1 O HIS A 708 N ILE A 704 SSBOND 1 CYS A 644 CYS A 893 1555 1555 2.03 LINK C PHE A 633 N YCM A 634 1555 1555 1.32 LINK C YCM A 634 N LEU A 635 1555 1555 1.33 SITE 1 AC1 7 ASN A 897 VAL A 901 LEU A 904 LEU A 912 SITE 2 AC1 7 CYS A 942 TRP A 945 PHE A 953 SITE 1 AC2 4 SER A 568 PRO A 569 VAL A 570 OLA A4004 SITE 1 AC3 5 TYR A 645 ILE A 649 PHE A 872 ILE A 873 SITE 2 AC3 5 OLA A4005 SITE 1 AC4 5 PRO A 569 CYS A 588 ILE A 636 OLA A4002 SITE 2 AC4 5 HOH A4130 SITE 1 AC5 2 TYR A 645 OLA A4003 SITE 1 AC6 9 TYR A 816 TYR A 890 ASN A 956 TYR A 957 SITE 2 AC6 9 LYS A 958 ILE A 959 HOH A4105 HOH A4176 SITE 3 AC6 9 HOH A4182 SITE 1 AC7 2 ARG A 574 ILE A 581 SITE 1 AC8 1 THR A 598 SITE 1 AC9 10 GLY A 624 SER A 654 PRO A 655 SER A 658 SITE 2 AC9 10 TYR A 659 ILE A 944 TRP A 945 PHE A 948 SITE 3 AC9 10 SER A 965 SER A 969 CRYST1 142.822 43.424 81.976 90.00 98.93 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007002 0.000000 0.001101 0.00000 SCALE2 0.000000 0.023029 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012348 0.00000